Concepedia

Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth

Tara Wenger, Sheila Ganti, Catherine Bull, Erika Lutsky, James T. Bennett, Kaitlyn Zenner, Dana M. Jensen, Victoria Dmyterko, Ezgi Mercan, Giridhar M. Shivaram,

Genetics in Medicine · 2022 · 43 citations · 36 references

DOIFull text

Open access

Concepts

References

36

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

Fabrice André, Eva Ciruelos, Gábor Rubovszky et al. · New England Journal of Medicine · 2019 · 2.6K citations · Full text

, , +17

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

Fabrice André, Eva Ciruelos, Dejan Juric et al. · Annals of Oncology · 2020 · 599 citations · Full text

, , +17

Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CA

Valerie L. Luks, Nolan Kamitaki, Matthew P. Vivero et al. · The Journal of Pediatrics · 2015 · 581 citations · Full text

, , +14

Targeted therapy in patients with PIK3CA-related overgrowth syndrome

Quitterie Venot, Thomas Blanc, Laureline Berteloot et al. · Nature · 2018 · 575 citations · Full text

, , +12

<i>PIK3CA</i>‐related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation

Kim M. Keppler‐Noreuil, Jonathan J. Rios, Victoria Parker et al. · American Journal of Medical Genetics Part A · 2014 · 572 citations · Full text

, , +17